WMCSU is currently collecting commissioning policies from commissioning organisations in the West Midlands region. In the future, these will be put into a database which will be searchable via our website.
Policies from the West Midlands Specialised Commissioning Team (WMSCT)
Model Commissioning Policies for West Midlands PCTs to review and consider adopting:
Choice
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
Experimental and Unproven Treatments
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
In Year Service Developments
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
Individual Funding Requests
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
Defining the boundaries between NHS and Private Healthcare
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
Implementation and funding of guidance produced by NICE
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
Patients changing responsible commissioner
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
Ongoing access to treatment following the completion of a trial explicitly funded by the Primary Care Trust
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
Ongoing access to treatment following the completion of industry sponsored clinical trials or funding
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
Ongoing access to treatment following the completion of non-commercially funded clinical trials
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
Ongoing access to treatment following a ‘trial of treatment’ which has not been sanctioned by the Primary Care Trust for a treatment
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
Patients Seeking NHS Funded Hospital Treatment in the European Union, European Economic Area or Switzerland
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
The Ethical Framework
• Full Policy (.doc)
• Equality Impact Assessment (.doc)
• Version Control (.pdf)
List of Definitions
• Full Policy (.doc)
• Version Control (.pdf)
Regional Treatment Specific Policies - for treatments which are only commissioned by WMSCT:
WM1 - PFO Migraine
WM2 - AIT Renal Transplant
WM3 - Cardiac Extracorporeal Life Support
WM4 - Targeted Therapies for the treatment of Pulmonary Arterial Hypertension
WM5 - Withdrawal of Sitaxsentan
WM6 - Plerixafor Interim Commissioning Policy
WM7 - Stereotactic Radiosurgery for Acoustic Neuroma
Regional Treament Specific Policies - for treatments which may be commissioned either by WMSCT or PCTs depending on the setting:
WM8 - Arrangements for patients affected by withdrawal of use of Palivizumab for prevention of RSV
Regional Treatment Specific Policies - operated by PCTs:
WM9 - Extra Corporeal Photopheresis
WM10 - Siklos - Sickle Cell Anaemia